Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The primary objectives are a) to establish the maximum tolerated dose of gemtuzumab
ozogamicin in combination with cytarabine and b) to assess the safety of gemtuzumab
ozogamicin when given concurrently with cytarabine.